Are you Dr. Oltvai?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 16 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
Rochester, NY 14642Phone+1 585-273-4135Fax+1 585-273-3637
Summary
- Dr. Zoltan Oltvai, MD is a board certified pathologist in Rochester, New York. He is currently licensed to practice medicine in New York, Minnesota, and Iowa. He is affiliated with Strong Memorial Hospital of the University of Rochester and is an Associate Professor at University of Pittsburgh School of Medicine.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1989 - 1994
Semmelweis UniversityClass of 1984
Certifications & Licensure
NY State Medical License 2019 - 2025
PA State Medical License 1994 - 2021
MN State Medical License 2018 - 2019
IA State Medical License 2017 - 2018
IL State Medical License 1994 - 2005- American Board of Pathology Clinical Pathology
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- 2 citationsClinicopathologic and Molecular Characterization of Anorectal Neuroendocrine Carcinomas Reveals Human Papillomavirus, p53, and c-Myc as Alternative Mechanisms of Carci...Allison J Cox, William E Crowe, Qi Yang, Bin Zhang, Zoltán N Oltvai
Modern Pathology. 2023-11-01 - 3 citationsAlterations in the omics profiles in mevalonate pathway-inhibited cancer cells.Tomoko Warita, Nanami Irie, Yaxuan Zhou, Jiro Tashiro, Akihiro Sugiura
Life Sciences. 2023-01-01 - 1 citationsIncidental discovery of acute myeloid leukemia during liquid biopsy of a lung cancer patient.Dingani Nkosi, Caroline A Miller, Audrey N Jajosky, Zoltán N Oltvai
Cold Spring Harbor Molecular Case Studies. 2022-06-01
Grant Support
- Integrated Antimicrobial Drug Discovery Scheme For Multidrug Resistant BacteriaNational Institute Of Allergy And Infectious Diseases2006–2010
- Antibiotic Target Identification Through Metabolic Network AnalysisNational Center For Research Resources2006
- System-Level Properties Of The E. Coli Metabolic NetworkNational Institute Of Allergy And Infectious Diseases2004–2006
- Antibiotic Target Identification Through Metabolic Network AnalysisNational Center For Research Resources2005
- System-Level Properties Of The E. Coli Metabolic NetworkNational Institute Of Allergy And Infectious Diseases2002–2004
- Mechanism &Regulation Of BCL-2 Antiproliferative EffectNational Cancer Institute1997–2001
- Function And Regulation Of Phosphorylated Bc1-2National Cancer Institute1996–2000
